Venus Biosciences Private Limited
About Venus Biosciences Private Limited
Data last updated:
Venus Biosciences Private Limited is a private limited company based in Solan, Himachal Pradesh, India. The company is currently undergoing Corporate Insolvency Resolution Process (CIRP) under the Insolvency and Bankruptcy Code, 2016. Management control has been transferred to an insolvency professional. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 July 2008.
The company is registered with the Registrar of Companies (ROC), Himachal Pradesh, under CIN U74999HP2008PTC031161. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹51 Lakh. It is led by directors Rakesh Kumar and Ramdeo Ram.
Its last annual general meeting (AGM) was held on 30 September 2016, and its latest financial statements are for the year ended 31 March 2016. The registered office is at Plot No.116 Epip Phase – 1 Village: Jharmajhri Baddi, Solan, Himachal Pradesh, India – 173205.
As per the financials filed for FY 2016, the company reported a revenue of ₹222.32 Cr, a growth of 48% compared to the previous year. For the same year it recorded a net profit of ₹5 Cr (net margin 2.2%) and EBITDA of ₹12.53 Cr (EBITDA margin 5.6%).
The company has about 32 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹40 Cr and satisfied charges of ₹136.77 Cr on record. Court records list 31 cases involving the company, including 15 filed by the company and 16 filed against it; 9 cases are pending. The company has 4 deals on record (2 funding rounds, 2 secondary share transfers), with disclosed funding of ₹7.6 Cr; the latest was in March 2016. Its 7 peer companies in the Pharma industry (Biosciences, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 3 smaller; the largest is Medopharm Private Limited with revenue of ₹229.32 Cr.
Company details
CIN history
Venus Biosciences has one previous CIN (Corporate Identification Number): U74999WB2008PTC127430. The current CIN is U74999HP2008PTC031161, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U74999HP2008PTC031161 | Current |
| U74999WB2008PTC127430 | Previous |
Contact details
Venus Biosciences Private Limited's registered office is in Solan, Himachal Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressPlot No.116 Epip Phase – 1 Village: Jharmajhri Baddi, Solan, Himachal Pradesh, India – 173205
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Venus Biosciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Venus Biosciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Venus Biosciences Private Limited, buy the company report.
Financials of Venus Biosciences Private Limited
FY 2016 filings availableVenus Biosciences Private Limited reported revenue of ₹222.32 Cr (up 48% YoY) for FY 2016.
Compounded Annual Growth Rate (CAGR)
Revenue rose 48% in the latest year. EBITDA rose 46% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2015-16 | FY 2014-15 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ₹222.32 Cr | |
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹12.53 Cr | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹5 Cr | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2015-16 | FY 2014-15 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 5.6% | |
| Net Profit Margin | 2.2% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Venus Biosciences Private Limited, buy the company report.
Board of directors of Venus Biosciences Private Limited
Venus Biosciences has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rakesh Kumar | Director | 19 May 2017 | 9 Years 5 Months | As last reported |
| Ramdeo Ram | Director | 01 Apr 2016 | 10 Years 7 Months | As last reported |
Peer comparison
Venus Biosciences Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Biosciences, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medopharm Private Limited | ₹229.32 Cr (FY 2025) | -9.0% | Chennai, Tamil Nadu, India | |||
| Hindustan Laboratories Limited | ₹227.37 Cr (FY 2025) | 17.0% | Mumbai, Maharashtra, India | |||
| Salvi Chemical Industries Limited | ₹225.29 Cr (FY 2025) | 47.0% | Mumbai, Maharashtra, India | |||
| Aura Pharmaceuticals Private Limited | ₹223.55 Cr (FY 2025) | 10.0% | Mumbai, Maharashtra, India | |||
| Venus Biosciences Private Limitedthis company | ₹222.32 Cr (FY 2016) | ₹5 Cr | 2.2% | 48.0% | 32 | Solan, Himachal Pradesh, India |
| Nestor Pharmaceuticals Limited | ₹222.19 Cr (FY 2025) | 8.0% | New Delhi, Delhi, India | |||
| Concept Pharmaceuticals Limited | ₹222.11 Cr (FY 2024) | -29.0% | Mumbai, Maharashtra, India | |||
| Naprod Life Sciences Private Limited | ₹219.65 Cr (FY 2025) | 1.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Venus Biosciences Private Limited, buy the company report.
Shareholding
The shareholding of Venus Biosciences Private Limited is on record for FY 2016, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2016 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Venus Biosciences Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 Mar 2015 | 10568210 | Syndicate Bank | ₹40 Cr | Open | |
| 29 Mar 2014 | 10487188 | State Bank of India | ₹69.25 Cr | Satisfied | |
| 22 Jul 2011 | 10303993 | State Bank of India | ₹28.75 Cr | Satisfied | |
| 21 Dec 2009 | 10198823 | Allahabad Bank (Lead Banker) | ₹13.64 Cr | Satisfied | |
| 13 Jul 2009 | 10167349 | Allahabad Bank (Lead Bank) | ₹17.64 Cr | Satisfied |
To see the full charge records of Venus Biosciences Private Limited, buy the company report.
Total charge records: 6 View all charges
Deals & funding
Venus Biosciences Private Limited has 4 deals on record (2 funding rounds, 2 secondary share transfers), with disclosed funding of ₹7.6 Cr; the latest was in March 2016.
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2016 | Secondary share transfer | Undisclosed | Buyer: Alka Properties Private Limited , MSB Properties Private Limited , Gayatri Drugs Private Limited Seller: Visa Pharma Generics Private Limited , Dolphin Pharma-Labs Private Limited , Well Worth Pharmaceuticals Private Limited |
| Mar 2015 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 4 individuals |
| Nov 2013 | Funding round | ₹5.6 Cr | Investors: Gayatri Generics Private Limited , Purna Reality Private Limited , MSB Properties Private Limited |
| Mar 2012 | Funding round | ₹2 Cr | Investors: Conceptual Biosciences Private Limited , Visa Pharma Generics Private Limited , Dolphin Pharma-Labs Private Limited |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Venus Biosciences Private Limited has 31 court cases on record: 15 filed by Venus Biosciences, 16 filed against it. 9 cases are pending and 22 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 24 | 11 | 7 |
| High courts | 7 | 5 | 2 |
Cases on record (5 of 31)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Karnal, Haryana | Civil suit | Filed against the company by Nivoxaa Biotech India Private Limited | Pending |
| District court, Solan, Himachal Pradesh | Cheque dishonour complaint | Filed by the company against Ms Capillon Pharma Pvt Limited | Disposed |
| District court, Chandigarh | Cheque dishonour complaint | Filed by the company against Ms Astalon Pharma Pvt. Ltd | Disposed |
| High Court, CHANDIGARH (UT) | Company petition | Filed by the company against M/S Megma Healthcare Pvt Ltd | Disposed |
| High Court, CHANDIGARH (UT) | Company petition | Filed by the company against M/S Astalon Pharma Pvt. Ltd. | Disposed |
To see the full case history of Venus Biosciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Venus Biosciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Venus Biosciences Private Limited has a workforce of 32 employees on its EPFO records as of Mar 28, 2024, across 1 active EPFO establishment.
GST
Venus Biosciences has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Venus Biosciences Private Limited, buy the company report.
Recent activity
Venus Biosciences Private Limited has 7 board changes on record since 2014: 2 appointments and 5 cessations. The latest: Pragya Balasaria ceased to be Director on 21 Jun 2018.
12 earlier events are in the company report.
Frequently asked questions
Venus Biosciences is undergoing "Corporate Insolvency Resolution Process" (CIRP) under the Insolvency and Bankruptcy Code, 2016. Management control has been transferred to an insolvency resolution professional. The company may not be able to independently enter into new commitments during this period. This is a high-risk status - verify the resolution status before any engagement.
Venus Biosciences is a company under insolvency, formerly operating as a private limited company based in Solan, Himachal Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 July 2008 and is registered under CIN U74999HP2008PTC031161. Caution is advised - the company may not have the legal capacity to fulfil new agreements.
Venus Biosciences has 2 current directors:
- Rakesh Kumar - Director
- Ramdeo Ram - Director
The latest financial statements of Venus Biosciences on record with the MCA are for the year ended 31 March 2016. Its last annual general meeting was held on 30 September 2016. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Venus Biosciences is U74999HP2008PTC031161. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Venus Biosciences has open charges of ₹40 Cr and satisfied charges of ₹136.77 Cr as per latest MCA filings.
Venus Biosciences has 31 court cases on record: 15 filed by the company and 16 filed against it. 9 are pending. Most are in the district courts.
Venus Biosciences was incorporated on 12 July 2008. It is registered with the Registrar of Companies, Himachal Pradesh.
Venus Biosciences has 4 deals on record (2 funding rounds, 2 secondary share transfers), with disclosed funding of ₹7.6 Cr; the latest was in March 2016.
The peers of Venus Biosciences by revenue are Medopharm Private Limited, Hindustan Laboratories Limited, Salvi Chemical Industries Limited, Aura Pharmaceuticals Private Limited, Nestor Pharmaceuticals Limited and 2 more, all in the Pharma industry (Biosciences, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Pragya Balasaria ceased to be Director on 21 Jun 2018. Phool Chandra Yadav ceased to be Director on 19 May 2017. Rakesh Kumar was appointed as Director on 19 May 2017. Venus Biosciences has 7 board changes on record in total.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
